Annual Scientific Report

Presentation
IDIBAPS Foreword
Introduction
We are very pleased to present the Scientific Memorandum of the Institut d’Investigacions Biomèdiques August Pi i Sunyer
(IDIBAPS), one of the first Health Care Research Institutes accredited by the Carlos III Health Institute in 2009. The research
activities of the centre are divided into five different areas, which group around 55 top-level research teams. This Memorandum
offers a summary of the objectives and configuration of each of these research teams, together with an exhaustive presentation
of the data relating to their scientific production. The objective of this document is to underscore the enormous potential of the
investigators of the IDIBAPS and to reflect the numerous financing entities and collaborators that make it all possible.
In addition to the information on the different areas, we have also included the research made by three transversal groups:
Primary Care, Clinical Pharmacology and Nursing – these groups are very important to ensure top-quality research and enhance
the valorisation and transfer of the knowledge gained to the patient. Moreover, a summary of the research made by the
Barcelona Centre for International Health Research (CRESIB) has also been included due to the tight collaboration between
the two CERCA institutes, since CRESIB was created from the IDIBAPS’ area 6 of International Health.
A good indicator of the good health of IDIBAPS is the number of publications made by its investigators. In 2010, IDIBAPS
published a total of 846 original articles in international journals, with a global impact factor of 4.176,72. This means an average
of 4,94 impact factor points per article – an important figure that adequately reflects the quality of our research which has
significantly increased from 2009.
All considered, we have nothing but admiration for the professionals who allow the Institute to advance, allowing us to view
the future with optimism. In this Memorandum you will find interesting lines of research and front-line initiatives. We have
achieved many things, but we can most certainly achieve many more. We have human potential, institutional and economical
support, and the desire to continue moving forward.
Management Report
1. Funding of IDIBAPS. The funding of IDIBAPS during
2010 totalled 18.339.000 Euros. Twenty three percent of this
amount corresponds to the contribution of the Department of Innovation,
Universities and Enterprise (Departament d’Innovació,
Universitats i Empresa) of the Catalan government (Generalitat
de Catalunya). The rest of the funding received by IDIBAPS during
2010 corresponds to calls for research funding (71%), as
well as contracts and cooperation agreements with private entities
(5%), and financial income sources (1%).
IDIBAPS FUNDING FINANTIAL YEAR 2010
COMPETITIVE
PROJECTS
(CALLS FOR
FUNDING)
13.031.000 €
PRIVATE FUNDING
948.000 €
FINANCIAL
INCOME
174.000 €
DIUE
CONTRIBUTION
4.186.000 €
2. Resource volume generated by the IDIBAPS researchers.
A significant aspect is the resource volume generated by
the IDIBAPS research groups. In this context, the resources
executed by researchers of the IDIBAPS during the financial
year corresponding to 2010 totalled 43.319.435 Euros. These
resources have been managed by different institutions:
IDIBAPS itself (12.622.559 Euro) and the Fundació Clínic per a
la Recerca Biomèdica (30.696.876 Euro).
It is important to mention that 63% of the resources executed by
investigators of IDIBAPS during 2010 (more than 27 MEuro) correspond
to competitive research projects and grant basis (calls
for funding). The remaining 37% is distributed as follows: 19%
contracts with private entities, 5% clinical trials managed by the
Fundació Clínic, 10% donations, and 4% teaching contracts.
RESOURCES GENERATED BY THE IDIBAPS
INVESTIGATORS IN 2010
COMPATITIVE
PROJECTS
27.098.759 € 63%
PRIVATE
FUNDING
8.380.685 € 19%
CLINICAL
TRIALS
2.011.198 € 5%
DONATIONS
4.205.317 € 10%
TEACHING
1.623.475 € 4%
8